Back to 
MACQUARIE GROUP LTD
MACQUARIE GROUP LTD
AMLX
Showing 1 of 2 quarters
Position history for MACQUARIE GROUP LTD's holdings in AMYLYX PHARMACEUTICALS INC
No. Macquarie Group exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 2,528 shares worth $4,803. Macquarie Group first reported AMLX in Q2 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History